Minimal effective dose of indomethacin for the treatment of patent ductus arteriosus in preterm infants.

Abstract

The aim of this study was to determine if it was possible to decrease the number of boluses of indomethacin for the treatment of patent ductus arteriosus. This retrospective study included 46 preterm neonates (<34 weeks' GA) who had had an ultrasound diagnosis predictive of subsequent symptomatic patent ductus arteriosus. All patients had received a daily… (More)

Topics

Cite this paper

@article{Roque2002MinimalED, title={Minimal effective dose of indomethacin for the treatment of patent ductus arteriosus in preterm infants.}, author={Eric Dumas de la Roque and Michael Fayon and Florence Babre and Jean Louis Demarquez and Laurence Pedespan}, journal={Biology of the neonate}, year={2002}, volume={81 2}, pages={91-4} }